兹拉坦·伊布拉西莫维奇（Zlatan Ibrahimović），简称伊布，1981年10月3日出生于 瑞典 马尔默，前瑞典职业 足球运动员，司职前锋。 [1] [109] 1999年，伊布在 马尔默足球俱乐部 开始职业生涯。 2001年，伊布转会至 阿贾克斯足球俱乐部。 同年入选国家队。 2004年，伊布加盟 尤文图斯足球俱乐部。 2006年，伊布加盟 国际米兰足球俱乐部。 2009年，伊布加盟 巴塞罗那足球俱乐部。 2010年，伊布转会至AC米兰足球俱乐部。 2012年，伊布加盟 巴黎圣日耳曼足球俱乐部，并 …

Zlatan Ibrahimović (born 3 October 1981) is a Swedish former professional footballer who played as a striker. Ibrahimović is known for his acrobatic strikes and volleys, technique, ball control, and physical dominance.

2024年10月24日 · The previously introduced iBRAB method relies on studied antibodies to design a broad-spectrum antibody capable of neutralizing antigens of many different Influenza A viral strains. To evaluate the antigen-binding fragment as an applicable drug, the therapeutic antibody profiles providing guidelines collected from clinically staged therapeutic ...

2020年12月31日 · We developed an in silico protocol called iBRAB to design a broad-reactive Fab on a wide range of influenza A virus. The Fab model was constructed based on sequences and structures of available broad-spectrum Abs or Fabs against a wide range of H1N1 influenza A …

2024年10月24日 · The previously introduced iBRAB method relies on studied antibodies to design a broad-spectrum antibody capable of neutralizing antigens of many different Influenza A viral strains. To evaluate the antigen-binding fragment as an applicable drug, the therapeutic antibody profiles providing guidelines collected from clinically staged therapeutic ...

2020年9月1日 · We developed an in silico protocol called iBRAB to design a broad-reactive Fab on a wide range of influenza A virus. The Fab model was constructed based on sequences and structure of available broad-spectrum Abs or Fabs against …

Zlatan Ibrahimović is the father of Vincent Ibrahimović (Milan Under 17). Loading... Malmö Anadolu BI (1989–1991), FBK Balkan (1991–1995), Malmö FF (1995–1999) Champions …

We developed an in silico protocol called i BRAB to design a broad-reactive Fab on a wide range of influenza A virus. The Fab model was constructed based on sequences and structures of available broad-spectrum Abs or Fabs against a wide range of H1N1 influenza A virus.

The previously introduced iBRAB method relies on studied antibodies to design a broad-spectrum antibody capable of neutralizing antigens of many different Influenza A viral strains. To evaluate the antigen-binding fragment as an applicable drug, t

Four distinct Escherichia coli immunoglobulin-binding (eib) genes, each of which encodes a surface-exposed protein that binds immunoglobulins in a nonimmune manner, are carried by separate prophages in E. coli reference (ECOR) strain ECOR-9.